D. Spaëth

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin

Jean-Louis Pujol, Jean-Luc Breton, R. Gervais et al. · Annals of Oncology · 2005 · 129 citations

Gemcitabine–docetaxel Versus Cisplatin–vinorelbine, Medicine, Anti-cancer Agent +8

Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer

Isabelle Treilleux, Mónica Arnedos, Claire Cropet et al. · Annals of Oncology · 2014 · 84 citations · Full text

Breast Oncology, Oncology, Translational Studies +7

Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study

Xavier Pivot, Jean‐Philippe Spano, Marc Espié et al. · European Journal of Cancer · 2017 · 65 citations

Trastuzumab Administration, Subcutaneous Versus, Breast Oncology +6

Abstract S1-6: TAMRAD: A GINECO Randomized Phase II Trial of Everolimus in Combination with Tamoxifen Versus Tamoxifen Alone in Patients (pts) with Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC) with Prior Exposure to Aromatase Inhibitors (AI).

T Bachelot, C. Bourgier, Claire Cropet et al. · Cancer Research · 2010 · 61 citations

Breast Oncology, Pharmacotherapy, Endocrine Oncology +16

Reduced Cellular Toxicity of a New Silver-Containing Antimicrobial Dressing and Clinical Performance in Non-Healing Wounds

Kathrin Ziegler, R. Görl, J. Effing et al. · Skin Pharmacology and Physiology · 2006 · 58 citations